Milton Greenberg
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2023 | NIH | SBIR Phase I Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder | $320K | VIVREON BIOSCIENCES LLC |
| Sep 1, 2020 | NIH | SBIR Phase I Investigation of Microglial CRAC Channels as a Novel Drug Target for Opioid Use Disorder | $405K | VIVREON BIOSCIENCES LLC |
| Aug 1, 2019 | NIH | SBIR Phase I Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease | $271K | VIVREON BIOSCIENCES LLC |
| Jul 1, 2017 | NIH | SBIR Phase I Predevelopment of VV a Novel CRAC Channel Inhibitor for the Treatment of Ulcerative Colitis | $220K | VIVREON BIOSCIENCES LLC |
| Sep 30, 2016 | NIH | SBIR Phase I Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease | $222K | VIVREON BIOSCIENCES LLC |
Peer ranks
Federal funding#1,441
Awards as PI#417
Patents#273
Companies
- VIVREON BIOSCIENCES LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.